Respiratory Function in Fibromiyalgia Syndrome
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07913126, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Karabuk University
- Trial code
- NCT07913126
- Record updated
- 3 November 2026
- Original description
Fibromyalgia is a condition that may lead to a decline in respiratory function, as well as impaired oxygen delivery to and utilization by the muscles-factors that contribute to fatigue and reduced exercise capacity. However, this aspect remains insufficiently studied and is not yet clearly understood. In this context, this study aims to compare upper extremity functional exercise capacity, respiratory and peripheral muscle strength, muscle oxygenation, pain, and quality of life in patients with fibromyalgia syndrome against those of healthy individuals.Read full original descriptionShow less
Investigation of Respiratory Functions and Functional Capacity in Female Patients With Fibromyalgia
Fibromyalgia is a condition that may lead to a decline in respiratory function, as well as impaired oxygen delivery to and utilization by the muscles-factors that contribute to fatigue and reduced exercise capacity. However, this aspect remains insufficiently studied and is not yet clearly understood. In this context, this study aims to compare upper extremity functional exercise capacity, respiratory and peripheral muscle strength, muscle oxygenation, pain, and quality of life in patients with fibromyalgia syndrome against those of healthy individuals.
Inclusion: For the fibromyalgia group:; Being a woman between the ages of 18 and 65,; Having a diagnosis of fibromyalgia-made by a rheumatologist or a specialist in physical medicine and rehabilitation-consistent with the 2016 American College of Rheumatology (ACR) criteria,; Having had the fibromyalgia diagnosis for at least 3 months; For the healthy control group:; Being a woman between the ages of 18 and 65,; Being a volunteer for the study.
Exclusion: Using medications that result in clinical instability,; Having severe orthopedic, neurological, or cardiac conditions,; Having an additional pulmonary disease,; Having a diagnosed coexisting rheumatic disease,; Not having any known chronic diseases,; Not being willing to participate in the study voluntarily; For the healthy control group:; Being willing to participate in the study voluntarily.